𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mitoxantrone (novantrone∗) as single agent and in combination chemotherapy in the treatment of advanced breast cancer

✍ Scribed by Smith, I.E.; Stuart-Harris, R.; Pavlidis, N.; Bozek, T.

Book ID
123472516
Publisher
Elsevier Science
Year
1983
Tongue
English
Weight
306 KB
Volume
10
Category
Article
ISSN
0305-7372

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First-line combination chemotherapy with
First-line combination chemotherapy with mitoxantrone and cyclophosphamide in advanced breast cancer
✍ P. Periti; G. Robustelli Delia Cuna; F. Pannuti; T. Mazzei; P. Preti; A. Martoni 📂 Article 📅 1985 🏛 Springer US 🌐 English ⚖ 312 KB

In this study, 30 evaluable patients with advanced carcinoma of the breast were treated with cyclophosphamide 600 mg/m2 i.v. followed one day later with mitoxantrone (Novantrone; dihydroxyanthracenedione) 16 mg/m2 i.v. Drug treatment was repeated every 3-4 weeks, for a maximum of 12 cycles. The over

Combination chemotherapy in the treatmen
Combination chemotherapy in the treatment of advanced breast cancer
✍ Dutzu Rosner; Takuma Nemoto; Chief Thomas L. Dao 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB

## Abstract Seventy‐two women with metastatic breast cancer were treated with multiple‐agent chemotherapy. Fifty women were treated with 5 drugs in combination: 5‐FU, methotrexate, vincristine, cytoxan, and prednisone; 22 were treated with the combination of 3 drugs: 5‐FU, cytoxan, and prednisone.